Blog
RSS FeedPosted by Michael Wonder on 18 Jun 2019
Advisory Council supports biosimilars in call for universal public drug coverage in Canada
17 June 2019 - A Canadian advisory council is recommending the use of biosimilars in a final report that lays ...
Posted by Michael Wonder on 17 Jun 2019
Canada already has a pharmacare system — and it's working
17 June 2019 - Why blow up a system that is mostly working and take on billions in new spending when ...
Posted by Michael Wonder on 17 Jun 2019
Patient with rare disease pleads for life-saving drug funding
17 June 2019 - 'You wait five years for the diagnosis, then they tell you, 'We're not going to fund you.' ...
Posted by Michael Wonder on 14 Jun 2019
Ontario grants broader access to Spinraza (nusinersen) for patients living with spinal muscular atrophy
13 June 2019 - Ontario joins Saskatchewan and Quebec to give patients with spinal muscular atrophy broader access to Spinraza. ...
Posted by Michael Wonder on 13 Jun 2019
Canada should have universal, single-payer public pharmacare, says advisory council
12 June 2019 - Canada should have a national pharmacare program that is universal, single payer and public, says an ...
Posted by Michael Wonder on 12 Jun 2019
Ford government to fund Spinraza, world’s most expensive drug - with age caps
12 June 2019 - The Ford government today announced it will be covering the cost of the drug Spinraza for ...
Posted by Michael Wonder on 12 Jun 2019
Canada will move on new drug price rules in 'very near future': minister
13 June 2019 - Work on the Canadian government’s proposal to crack down on patented drug prices is underway and ...
Posted by Michael Wonder on 08 Jun 2019
'Equity issue:' Saskatchewan to fully cover cost of abortion drug Mifegymiso
7 June 2019 - Advocates are celebrating the Saskatchewan government's decision to fully fund the cost of the abortion drug ...
Posted by Michael Wonder on 06 Jun 2019
Patients, physicians raise concerns with BC biosimilar non-medical switching policy
6 June 2019 - On 27 May, the Government of British Columbia announced a policy that will forcibly switch thousands ...
Posted by Michael Wonder on 03 Jun 2019
Canada to limit scope of new drug price rules
29 May 2019 - The federal government has assured the pharmaceutical industry that new features of its plan to cut ...
Posted by Michael Wonder on 30 May 2019
Use of real world data sources for Canadian drug pricing and reimbursement decisions: stakeholder views and lessons for other countries
29 May 2019 - Canada has a long history of the use of clinical evidence to support health care decision making. ...
Posted by Michael Wonder on 29 May 2019
Canada told drug makers it would limit scope of some new price rules
29 May 2019 - The Canadian government has assured the pharmaceutical industry that new features of its plan to cut ...
Posted by Michael Wonder on 29 May 2019
Prices of Canadian generic medicines below international average
29 May 2019 - PMRPB: Canadian price declines steepest of all OECD countries. ...
Posted by Michael Wonder on 28 May 2019
Canadian Biosimilars Forum applauds B.C. Government's landmark decision to enhance adoption of biosimilars and calls on remaining provinces to follow
27 May 2019 - The Canadian Biosimilars Forum today commends the Government of British Columbia for taking a decisive step ...
Posted by Michael Wonder on 28 May 2019
BC PharmaCare’s Biosimilars Initiative an important step towards improving patient access to safe and effective medicines
27 May 2019 - Biosimilars Initiative implementation could contribute to significant cost savings for the BC health care system. ...